Adipose-Derived Mesenchymal Stromal Cells Treated with Interleukin 1 Beta Produced Chondro-Protective Vesicles Able to Fast Penetrate in Cartilage
- PMID: 34066077
- PMCID: PMC8151616
- DOI: 10.3390/cells10051180
Adipose-Derived Mesenchymal Stromal Cells Treated with Interleukin 1 Beta Produced Chondro-Protective Vesicles Able to Fast Penetrate in Cartilage
Abstract
The study of the miRNA cargo embedded in extracellular vesicles (EVs) released from adipose-derived mesenchymal stromal cells (ASC) preconditioned with IL-1β, an inflammatory stimulus driving osteoarthritis (OA), along with EVs-cartilage dynamic interaction represent poorly explored fields and are the purpose of the present research. ASCs were isolated from subcutaneous adipose tissue and EVs collected by ultracentrifugation. Shuttled miRNAs were scored by high-throughput screening and analyzed through bioinformatics approach that predicted the potentially modulated OA-related pathways. Fluorescently labeled EVs incorporation into OA cartilage explants was followed in vitro by time-lapse coherent anti-Stokes Raman scattering; second harmonic generation and two-photon excited fluorescence. After IL-1β preconditioning, 7 miRNA were up-regulated, 4 down-regulated, 37 activated and 17 silenced. Bioinformatics allowed to identify miRNAs and target genes mainly involved in Wnt, Notch, TGFβ and Indian hedgehog (IHH) pathways, cartilage homeostasis, immune/inflammatory responses, cell senescence and autophagy. As well, ASC-EVs steadily diffuse in cartilage cells and matrix, reaching a plateau 16 h after administration. Overall, ASCs preconditioned with IL-1β allows secretion of EVs embedded with a chondro-protective miRNA cargo, able to fast penetrate in collagen-rich areas of cartilage with tissue saturation in a day. Further functional studies exploring the EVs dose-effects are needed to achieve clinical relevance.
Keywords: adipose-derived mesenchymal stromal cells; cartilage; extracellular vesicles; interleukin 1 beta; miRNA; nonlinear optical microscopy; osteoarthritis; time-lapse.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





Similar articles
-
Interaction with hyaluronan matrix and miRNA cargo as contributors for in vitro potential of mesenchymal stem cell-derived extracellular vesicles in a model of human osteoarthritic synoviocytes.Stem Cell Res Ther. 2019 Mar 29;10(1):109. doi: 10.1186/s13287-019-1215-z. Stem Cell Res Ther. 2019. PMID: 30922413 Free PMC article.
-
Cartilage progenitor cells derived extracellular vesicles-based cell-free strategy for osteoarthritis treatment by efficient inflammation inhibition and extracellular matrix homeostasis restoration.J Nanobiotechnology. 2024 Jun 19;22(1):345. doi: 10.1186/s12951-024-02632-z. J Nanobiotechnology. 2024. PMID: 38890638 Free PMC article.
-
Synovial mesenchymal stem cell-derived extracellular vesicles containing microRN555A-26a-5p ameliorate cartilage damage of osteoarthritis.J Gene Med. 2021 Nov;23(11):e3379. doi: 10.1002/jgm.3379. Epub 2021 Aug 11. J Gene Med. 2021. PMID: 34296780
-
Roles of Exosomes from Mesenchymal Stem Cells in Treating Osteoarthritis.Cell Reprogram. 2020 Jun;22(3):107-117. doi: 10.1089/cell.2019.0098. Epub 2020 May 4. Cell Reprogram. 2020. PMID: 32364765 Review.
-
MSC-EVs alleviate osteoarthritis by regulating microenvironmental cells in the articular cavity and maintaining cartilage matrix homeostasis.Ageing Res Rev. 2023 Mar;85:101864. doi: 10.1016/j.arr.2023.101864. Epub 2023 Jan 24. Ageing Res Rev. 2023. PMID: 36707035 Review.
Cited by
-
Immunomodulatory potential of secretome from cartilage cells and mesenchymal stromal cells in an arthritic context: From predictive fiction toward reality.Front Med (Lausanne). 2022 Oct 12;9:992386. doi: 10.3389/fmed.2022.992386. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36314003 Free PMC article.
-
Mesenchymal stromal cells-derived extracellular vesicles in cartilage regeneration: potential and limitations.Stem Cell Res Ther. 2025 Jan 23;16(1):11. doi: 10.1186/s13287-025-04135-6. Stem Cell Res Ther. 2025. PMID: 39849578 Free PMC article.
-
Small Extracellular Vesicles from Inflamed Adipose Derived Stromal Cells Enhance the NF-κB-Dependent Inflammatory/Catabolic Environment of Osteoarthritis.Stem Cells Int. 2022 Jul 18;2022:9376338. doi: 10.1155/2022/9376338. eCollection 2022. Stem Cells Int. 2022. PMID: 35898656 Free PMC article.
-
Joint Tissue Protective and Immune-Modulating miRNA Landscape of Mesenchymal Stromal Cell-Derived Extracellular Vesicles under Different Osteoarthritis-Mimicking Conditions.Pharmaceutics. 2022 Jul 2;14(7):1400. doi: 10.3390/pharmaceutics14071400. Pharmaceutics. 2022. PMID: 35890296 Free PMC article.
-
Nanomaterial-Based Drug Delivery Systems Targeting Functional Cells for Osteoarthritis Treatment: Mechanisms, Challenges and Future Prospects.Int J Nanomedicine. 2025 Apr 25;20:5291-5320. doi: 10.2147/IJN.S518935. eCollection 2025. Int J Nanomedicine. 2025. PMID: 40303574 Free PMC article. Review.
References
-
- De Luca P., Kouroupis D., Viganò M., Perucca-Orfei C., Kaplan L., Zagra L., de Girolamo L., Correa D., Colombini A. Human Diseased Articular Cartilage Con-tains a Mesenchymal Stem Cell-Like Population of Chondroprogenitors with Strong Immunomodulatory Responses. J. Clin. Med. 2019;8:423. doi: 10.3390/jcm8040423. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous